Abstract
Cochlear implants (CIs) restore hearing in patients with severe to profound deafness by delivering electrical stimuli inside the cochlea. Understanding CI stimulus spread, and how it correlates to patient-dependent factors, is hampered by the poor accessibility of the inner ear and by the lack of suitable in vitro, in vivo or in silico models. Here, we present 3D printing-neural network co-modelling for interpreting clinical electric field imaging (EFI) profiles of CI patients. With tuneable electro-anatomy, the 3D printed cochleae were shown to replicate clinical scenarios of EFI profiles at the off-stimuli positions. The co-modelling framework demonstrated autonomous and robust predictions of patient EFI or cochlear geometry, unfolded the electro-anatomical factors causing CI stimulus spread, assisted on-demand printing for CI testing, and inferred patients’ in vivo cochlear tissue resistivity (estimated mean = 6.6 kΩcm) by CI telemetry. We anticipate our framework will facilitate physical modelling and digital twin innovations for electrical prostheses in healthcare.
Competing Interest Statement
M.B. received research funding from Advanced Bionics®, Cochlear Corporation®, and in-kind contribution from MED-EL® on other research areas but not on the present study. The remaining authors declare no competing interests.
Funding Statement
This work was supported by the European Research Council (ERC-StG, 758865), the Cambridge Hearing Trust and the Evelyn Trust. We thank Advanced Bionics Corporation® for providing cochlear implants and software on this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of anonymous patient EFI profiles and CT scans in our study was approved by the Cambridge Biomedical Research Centre (Ref: A095451).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript updated with new clinical data, and characterisations.
Data Availability
The raw data generated in the study are available for research purposes from the corresponding author upon appropriate request.
